Calcimedica Common Stock Stock Performance
| CALC Stock | 0.61 0.06 8.96% |
The firm shows a Beta (market volatility) of 2.16, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CalciMedica Common will likely underperform. At this point, CalciMedica Common Stock has a negative expected return of -1.24%. Please make sure to confirm CalciMedica Common's treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if CalciMedica Common Stock performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CalciMedica Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in March 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor 1:14 | Last Split Date 2023-03-20 |
1 | 424B5 CalciMedica, Inc. Prospectus Supplement - Stock Titan | 11/06/2025 |
2 | CalciMedica Presents Data from Preclinical Study of Auxora in an Animal Model of AKI at ASN Kidney Week 2025 | 11/10/2025 |
3 | Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial - Investing.com | 12/02/2025 |
4 | CalciMedica Trading Down 2.1 percent - Time to Sell - MarketBeat | 12/31/2025 |
| Begin Period Cash Flow | 5.5 M | |
| Total Cashflows From Investing Activities | -4.4 M |
CalciMedica | Build AI portfolio with CalciMedica Stock |
CalciMedica Common Relative Risk vs. Return Landscape
If you would invest 304.00 in CalciMedica Common Stock on November 7, 2025 and sell it today you would lose (243.00) from holding CalciMedica Common Stock or give up 79.93% of portfolio value over 90 days. CalciMedica Common Stock is currently does not generate positive expected returns and assumes 12.9034% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CalciMedica, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CalciMedica Common Target Price Odds to finish over Current Price
The tendency of CalciMedica Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.61 | 90 days | 0.61 | close to 99 |
Based on a normal probability distribution, the odds of CalciMedica Common to move above the current price in 90 days from now is close to 99 (This CalciMedica Common Stock probability density function shows the probability of CalciMedica Stock to fall within a particular range of prices over 90 days) .
CalciMedica Common Price Density |
| Price |
Predictive Modules for CalciMedica Common
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CalciMedica Common Stock. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CalciMedica Common Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CalciMedica Common is not an exception. The market had few large corrections towards the CalciMedica Common's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CalciMedica Common Stock, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CalciMedica Common within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.22 | |
β | Beta against Dow Jones | 2.16 | |
σ | Overall volatility | 1.49 | |
Ir | Information ratio | -0.09 |
CalciMedica Common Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CalciMedica Common for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CalciMedica Common Stock can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CalciMedica Common generated a negative expected return over the last 90 days | |
| CalciMedica Common has high historical volatility and very poor performance | |
| CalciMedica Common has some characteristics of a very speculative penny stock | |
| CalciMedica Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (13.7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CalciMedica Common generates negative cash flow from operations | |
| About 56.0% of the company shares are held by institutions such as insurance companies |
CalciMedica Common Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CalciMedica Stock often depends not only on the future outlook of the current and potential CalciMedica Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CalciMedica Common's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.2 M | |
| Cash And Short Term Investments | 18.7 M |
CalciMedica Common Fundamentals Growth
CalciMedica Stock prices reflect investors' perceptions of the future prospects and financial health of CalciMedica Common, and CalciMedica Common fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CalciMedica Stock performance.
| Return On Equity | -5.26 | ||||
| Return On Asset | -1.0 | ||||
| Current Valuation | 4.47 M | ||||
| Shares Outstanding | 14.41 M | ||||
| Price To Book | 6.98 X | ||||
| EBITDA | (24.15 M) | ||||
| Net Income | (13.7 M) | ||||
| Total Debt | 5.38 M | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (21.15 M) | ||||
| Earnings Per Share | (1.62) X | ||||
| Market Capitalization | 8.78 M | ||||
| Total Asset | 19.79 M | ||||
| Retained Earnings | (159.76 M) | ||||
| Working Capital | 15.98 M | ||||
About CalciMedica Common Performance
By analyzing CalciMedica Common's fundamental ratios, stakeholders can gain valuable insights into CalciMedica Common's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CalciMedica Common has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CalciMedica Common has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (13.29) | (13.96) | |
| Return On Tangible Assets | (0.80) | (0.84) | |
| Return On Capital Employed | (1.35) | (1.28) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (1.09) | (1.15) |
Things to note about CalciMedica Common Stock performance evaluation
Checking the ongoing alerts about CalciMedica Common for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CalciMedica Common Stock help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CalciMedica Common generated a negative expected return over the last 90 days | |
| CalciMedica Common has high historical volatility and very poor performance | |
| CalciMedica Common has some characteristics of a very speculative penny stock | |
| CalciMedica Common has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (13.7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CalciMedica Common generates negative cash flow from operations | |
| About 56.0% of the company shares are held by institutions such as insurance companies |
- Analyzing CalciMedica Common's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CalciMedica Common's stock is overvalued or undervalued compared to its peers.
- Examining CalciMedica Common's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CalciMedica Common's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CalciMedica Common's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CalciMedica Common's stock. These opinions can provide insight into CalciMedica Common's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CalciMedica Stock analysis
When running CalciMedica Common's price analysis, check to measure CalciMedica Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica Common is operating at the current time. Most of CalciMedica Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica Common's price. Additionally, you may evaluate how the addition of CalciMedica Common to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |